drugset / Trial / NCT00838968

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

NCT00838968

Withdrawn Fudan University
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to determine whether interferon-alpha is effective in the treatment of p48 Positive patients with HCC after curative resection.

Timeline

Start
2008-01
Primary completion
2012-10
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator interferon alfa-2b Protein / enzyme biologic 3e+06 iu Intramuscular
Comparator interferon alfa-2b Protein / enzyme biologic 5e+06 iu Intramuscular